ALCEDIAG (Now ALCEN)

Company Snapshot

Founded: 2013
Entity Type: Private
Region: France
Headquarter: Montpellier, France
Key Geographics: Europe
Corporate Address: Parc Euromedecine – Cap Gamma 1682 rue de la Valsière 34184 Montpellier France www.alcediag-alcen.com/

Company Overview

Alcediag Alcen is developing and commercializing molecular diagnostics for the psychiatric market. The company’s technology uses NGS and is based on analysis of RNA editing as biomarkers for psychiatric diagnosis of patients.

Alcediag’s initial product is Editox, which is an in vitro cell line assay that can identify the risk that a drug compound will cause severe depression or suicide.

Alcediag’s Editdiag liquid biopsy test analyzes five RNA biomarkers from a patient’s blood sample and uses Illumina’s NGS platform. The product is designed to be given to patients who visit a psychiatric emergency room, and to assist psychiatrists who are evaluating treatment options during the first two-day window.

ALCEDIAG (Now ALCEN) In Reports

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

BCC Market Research Report for global liquid biopsy research tools, liquid biopsy biomarkers, technologies, services and diagnostics markets.

Company's Business Segments

  • Diagnostic Solutions : This segment inclues Blood test to differentiate Unipolar Depression from Bipolar disorder, Cell-based solutions to Mimic Drug Impact on RNA Editing, Integrated platform from RNA / DNA sequencing to Machine Learning and AI.

Applications/End User Industries

  • Diagnostic
  • Life Sciences
  • Artificial Intelligence
  • Machine Learning
  • Cell-Based Solutions
  • Blood Tests
  • Bipolar Disorder
  • Mental Health
AI Sentiment